{
  "compound": "Endocannabinoid system modulation",
  "condition": "IBD_CROHNS",
  "effect_size": "N/A (review)",
  "study_type": "MECHANISTIC",
  "source": "NORML:IBD_MECHANISTIC_001",
  "participants": "Comprehensive review of preclinical/clinical evidence",
  "year": 2015,
  "notes": "Endocannabinoid System in IBD: Therapeutic Target Review",
  "confidence": "medium",
  "abstract": "CB1/CB2 receptor upregulation in inflamed mucosa; Anti-inflammatory: TNF-\u03b1\u2193, IL-1\u03b2\u2193, IL-6\u2193; Gut motility regulation; Epithelial barrier protection"
}